Is the US prepared to deal with another pandemic or widespread health crisis?

Is the US Prepared for Another Pandemic?

Based on current assessments from public health experts, government watchdogs, and policy analysts, the consensus leans heavily toward no — the US is widely viewed as less prepared today than it was even during the COVID-19 pandemic, due to a combination of structural vulnerabilities and recent policy decisions.

Structural Weaknesses Predate Recent Changes

Even before recent cuts, the US had underlying vulnerabilities. A Council on Foreign Relations Task Force assessment found that America's preparations provided "the illusion, but not the reality, of preparedness," noting the pandemic exposed the gap between having systems and being able to use them under pressure. The US also ranked near the bottom among comparable high-income countries in physicians per capita and had among the lowest hospital bed ratios, below the OECD average.

Recent Policy Changes Have Weakened Defenses

According to Bloomberg's 2026 analysis, pandemic preparedness fundamentals include a robust public health infrastructure with strong surveillance, research investment for treatments/vaccines, and public trust—and on each front, health experts say steps taken by the Trump administration have weakened the US's ability to respond to a new health emergency.

Funding cuts are substantial:

Workforce losses:
CDC lost approximately one quarter of its civilian workforce between fiscal years 2024 and 2026, with similar losses at the Health Resources and Services Administration, which funds community health centers and workforce development.

Global surveillance capacity reduced:
The U.S. formally completed its withdrawal from the WHO in January 2026, reducing access to global data that supports outbreak tracking, while the dissolution of USAID and CDC global health cuts have further curtailed international disease surveillance that served as an early-warning system.

Public Trust and Vaccine Hesitancy

A backlash against public health measures has elevated anti-vaccine activists and hostility toward vaccines, including the mRNA platform that helped end the COVID emergency—and experts like epidemiologist Michael Osterholm believe the current administration, which includes strong anti-vaccine voices, has made the US less prepared.

A More Nuanced View

Not everyone frames the picture as entirely bleak. The administration's 2025 "America First Global Health Strategy" included goals of enabling early detection and containment of outbreaks, and the Center for Global Development noted it signaled continued commitment to pandemic prevention, even while criticizing broader cuts. Georgetown's Rebecca Katz also cautions against doom-and-gloom framing, noting the reality is more nuanced, with different parts of the world investing in pandemic preparedness in various ways.

Legislative Response

There is some bipartisan effort to address specific risks: Senators Rand Paul and Gary Peters have sponsored the Risky Research Review Act, which would create an independent board of scientific and national security experts to approve federal funding for potentially dangerous gain-of-function research.

Bottom Line

The weight of expert opinion—from public health researchers, former CDC officials, and nonpartisan watchdog groups—suggests the US has moved in the wrong direction on pandemic readiness due to funding cuts, workforce reductions, withdrawal from international health cooperation, and declining public trust in vaccines. However, this reflects a snapshot of ongoing policy debates and proposed (not always finalized) budget cuts, some of which remain contested in Congress and the courts.